Center for Scientific Review; Amended Notice of Meeting, 28261 [2010-12145]

Download as PDF Federal Register / Vol. 75, No. 97 / Thursday, May 20, 2010 / Notices wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Reducing Cardiovascular Disease Risk Through Treatment of Obstructive Sleep Apnea. Date: June 3, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Harborplace Hotel, 202 East Pratt Street, Baltimore, MD 21202. Contact Person: David A Wilson, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7204, Bethesda, MD 20892–7924, 301–435–0299, wilsonda2@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Planning Grants for Clinical Trials of Novel Therapies in Lung Transplantation. Date: June 3, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Keary A Cope, PhD, Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7190, Bethesda, MD 20892–7924, (301) 435–2222, copeka@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Phase II Clinical Trials of Novel Therapies for Lung Diseases. Date: June 10, 2010. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: YingYing Li-Smerin, MD, PhD, Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20892– 7924, 301–435–0277, lismerin@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Coordination Core for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE). Date: June 16, 2010. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Stephanie J. Webb, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892, 301–435–0291, stephanie.webb@nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; VerDate Mar<15>2010 15:45 May 19, 2010 Jkt 220001 Cellular and Molecular Mechanisms of Arterial Stiffening and Its Relationship to Development of Hypertension. Date: June 17, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Robert T. Su, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7202, Bethesda, MD 20892–7924, 301–435–0297, sur@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Clinical Investigator and Research Scientist Career Development Awards. Date: June 17–18, 2010. Time: 8 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Marriott Crystal City, 2899 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Robert Blaine Moore, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7213, Bethesda, MD 20892, 301–594–8394, mooreb@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: May 14, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–12150 Filed 5–19–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Clinical Neuroscience and Neurodegeneration Study Section, June 3, 2010, 8 a.m. to June 4, 2010, 5 p.m., Washington Plaza Hotel, 10 Thomas Circle, NW., Washington, DC 20005 which was published in the Federal Register on May 7, 2010, 75 FR 25273–25275. The meeting will be one day only, June 3, 2010, from 8 a.m. to 6:30 p.m. The meeting location remains the same. The meeting is closed to the public. PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 28261 Dated: May 17, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–12145 Filed 5–19–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, June 4, 2010, 2 p.m. to June 4, 2010, 4 p.m., Grand Hyatt Seattle, 721 Pine Street, Seattle, WA 98101 which was published in the Federal Register on May 11, 2010, 75 FR 26261–26262. The meeting has been changed to a telephone assisted meeting at the National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. The meeting date and time have been changed to June 11, 2010, from 1 p.m. to 2 p.m. The meeting is closed to the public. Dated: May 14, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–12143 Filed 5–19–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Improved Diagnostics for Lyme Borreliosis, Funding Opportunity Announcement (FOA) CK10–005; Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: TIME AND DATE: 12 p.m.–3 p.m., June 22, 2010 (Closed). PLACE: Teleconference. STATUS: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. E:\FR\FM\20MYN1.SGM 20MYN1

Agencies

[Federal Register Volume 75, Number 97 (Thursday, May 20, 2010)]
[Notices]
[Page 28261]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12145]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Clinical 
Neuroscience and Neurodegeneration Study Section, June 3, 2010, 8 a.m. 
to June 4, 2010, 5 p.m., Washington Plaza Hotel, 10 Thomas Circle, NW., 
Washington, DC 20005 which was published in the Federal Register on May 
7, 2010, 75 FR 25273-25275.
    The meeting will be one day only, June 3, 2010, from 8 a.m. to 6:30 
p.m. The meeting location remains the same. The meeting is closed to 
the public.

    Dated: May 17, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-12145 Filed 5-19-10; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.